Sidi Yang

Guangzhou International Bio Island
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

An Engineered HR1-Stem Helix-HR2 Trimeric Platform for Developing Broad-Spectrum Coronavirus Vaccines.

An Engineered HR1-Stem Helix-HR2 Trimeric Platform for Developing Broad-Spectrum Coronavirus Vaccines.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 28, 2026

ZDHHC18-Mediated Palmitoylation of ORF3a Promotes SARS-CoV-2 Pathogenesis by Antagonizing TRIM16-Mediated Ubiquitination and Proteasomal Degradation.

ZDHHC18-Mediated Palmitoylation of ORF3a Promotes SARS-CoV-2 Pathogenesis by Antagonizing TRIM16-Mediated Ubiquitination and Proteasomal Degradation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 22, 2025

Reprogramming gut microenvironment for the treatment of acute severe ulcerative colitis via a synergistic therapy of necroptosis blockade and organoid transplantation.

Reprogramming gut microenvironment for the treatment of acute severe ulcerative colitis via a synergistic therapy of necroptosis blockade and organoid transplantation.

Journal: Nature communications
Published: September 26, 2025

Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release.

Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release.

Journal: Cell reports
Published: September 04, 2025

Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity.

Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity.

Journal: ACS infectious diseases
Published: July 17, 2025

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative.

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative.

Journal: Acta pharmaceutica Sinica. B
Published: April 08, 2025

Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment.

Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment.

Journal: Bioorganic & medicinal chemistry letters
Published: February 21, 2025

Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Journal: Nature communications
Published: January 21, 2025

Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses.

Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses.

Journal: Acta pharmaceutica Sinica. B
Published: October 14, 2024

Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities.

Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities.

Journal: Bioorganic chemistry
Published: September 26, 2024

Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High-Throughput Antiviral Screening Using Gibson DNA Assembly.

Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High-Throughput Antiviral Screening Using Gibson DNA Assembly.

Journal: Journal of medical virology
Published: September 19, 2024

Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection.

Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection.

Journal: Bioorganic chemistry
Published: September 06, 2024
Showing 1-12 of 24

Last Updated: 09/26/2026